Tratamiento farmacológico de la obesidad.
More than 70% of the population in Mexico is overweight or obese, affecting mainly people in productive age. Obesity is associated with the development of diseases that increase cardiovascular risk (diabetes mellitus, hypertension or atherogenic dyslipidemia), diseases that limit the quality of life...
| Publicado en: | Revista Medica del IMSS Vol. 56; no. 4; pp. 395 - 410 |
|---|---|
| Autores principales: | , , |
| Formato: | Artículo |
| Publicado: |
Direccion de Prestaciones Medicas - IMSS
jul/ago2018
|
| Acceso en línea: | Ver este registro en EBSCOhost |